(Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | (FY)Oct 31, 2022 | (Q4)Oct 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -36.23%-10.65K | -505.47%-120.77K | -115.07%-8.46K | 88.48%-11.14K | -185.06%-39.5K | 92.70%-7.82K | -19.95K | 255.56%56.12K | 87.55%-96.71K | 333.28%46.43K |
Net income from continuing operations | 58.83%-25.78K | 30.85%-27.65K | -20.85%-33.35K | -180.36%-191.12K | -150.15%-60.91K | 47.63%-62.63K | ---39.99K | 60.58%-27.6K | 83.20%-68.17K | 188.30%121.44K |
Depreciation and amortization | -19.23%84 | -21.62%87 | -18.97%94 | -18.83%431 | -18.03%100 | -60.75%104 | --111 | -19.44%116 | -19.30%531 | -19.74%122 |
Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --1K | ---- |
Other non cashItems | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---11.7K | ---- |
Change In working capital | -72.50%15.05K | -567.59%-93.2K | -70.34%24.8K | 1,077.07%179.55K | 133.07%21.31K | 346.31%54.7K | --19.93K | 147.37%83.6K | 95.05%-18.38K | -154.85%-64.43K |
-Change in receivables | -15.24%-877 | -88.31%-2.82K | -100.46%-1.03K | 214.53%219.03K | 99.55%-833 | 80.27%-761 | ---1.5K | 11,723.44%222.12K | -1,612.65%-191.25K | -9,787.15%-185.48K |
-Change in prepaid assets | ---- | ---- | ---- | 180.38%4.41K | --0 | ---- | ---- | ---- | -319.52%-5.49K | -143.32%-2.17K |
-Change in payables and accrued expense | -68.81%15.92K | -521.77%-90.38K | 118.65%25.83K | -124.61%-43.9K | -82.03%22.14K | 162.66%51.05K | --21.43K | -487.93%-138.52K | 149.15%178.36K | 7.76%123.22K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -36.23%-10.65K | -505.47%-120.77K | -115.07%-8.46K | 88.48%-11.14K | -185.06%-39.5K | 92.70%-7.82K | ---19.95K | 255.56%56.12K | 87.55%-96.71K | 333.28%46.43K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -2K | 0 | ||||||||
Net PPE purchase and sale | ---- | ---- | ---- | ---2K | ---- | ---- | ---- | ---- | --0 | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | ---- | ---- | ---- | ---2K | ---- | ---- | ---- | ---- | --0 | --0 |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 0 | 0 | ||||||||
Net common stock issuance | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net cash flow | ||||||||||
Beginning cash position | -24.22%51.77K | -86.11%12.54K | -38.49%21K | -73.91%34.14K | 35.31%60.5K | -27.92%68.32K | -4.76%90.26K | -73.91%34.14K | -47.79%130.85K | -78.66%44.71K |
Current changes in cash | -36.23%-10.65K | 278.78%39.23K | -115.07%-8.46K | 86.41%-13.14K | -273.77%-39.5K | 84.38%-7.82K | ---21.95K | 255.56%56.12K | 19.25%-96.71K | 86.56%-10.57K |
End cash Position | -32.03%41.12K | -24.22%51.77K | -86.11%12.54K | -38.49%21K | -38.49%21K | 35.31%60.5K | -27.92%68.32K | -4.76%90.26K | -73.91%34.14K | -73.91%34.14K |
Free cash from | -36.23%-10.65K | -505.47%-120.77K | -115.07%-8.46K | 86.41%-13.14K | -189.37%-41.5K | 92.70%-7.82K | ---19.95K | 255.56%56.12K | 87.55%-96.71K | 333.28%46.43K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data